VEGFA and cancer: In the initial phase I study of BEV in patients with advanced cancers, Gordon et al. [23] reported a decrease of free VEGF and a parallel increase of total concentration, possibly reflecting changes in both free and BEV-bound VEGF or the extensive loading of the extracellular matrix with VEGF in patients with advanced cancers [24].